Trifluridine Tipiracil,Bevacizumab,Bevacizumab
roche,Pfizer,Taiho pharma
['beva ', 'solstice', 'ts,perio,i', 'ts,perio,1', 'sunlight study']
#asco23 solstice: overall survival results for ftd-tpi + beva vs cape + beva first line, ineligible for intensive cht, 858 pts mpfs 9.4 vs 9.3 mo
mos 19.7 vs 18.6 mo ftd/tpi+beva is not superior to cape+beva in the recently published sunlight study, ftd-tpi + beva was 
Medical Oncologist.                                            
        
On the trail of #SCIENCE to turn cancer into a manageable chronic disease. #bcsm #crcsm